NovaBay Pharmaceuticals, Inc. Logo

NovaBay Pharmaceuticals, Inc.

Develops and commercializes eyecare, skincare, and wound care products.

NBY | US

Overview

Corporate Details

ISIN(s):
US66987P2011
LEI:
Country:
United States of America
Address:
2000 POWELL STREET, SUITE 1150, 94608 EMERYVILLE

Description

NovaBay Pharmaceuticals, Inc. is a biopharmaceutical company that develops and commercializes scientifically-created and clinically-proven products for the eyecare, skincare, and wound care markets. The company's core technology is a proprietary, stable formulation of hypochlorous acid. Its leading product is Avenova®, an antimicrobial lid and lash solution available over-the-counter for eye hygiene. In the wound care sector, NovaBay manufactures and sells products under the NeutroPhase® and PhaseOne® brands, which utilize its hypochlorous acid technology to aid in cleansing and debridement. The company focuses on providing accessible, problem-solving solutions for improved well-being.

Unlock This Filing & Millions More

You're one step away from the data you need. Create a free account to instantly view this filing and get access to powerful research tools.

Filings

You have of free filing views remaining. Upgrade for unlimited access.

Filters

Clear
Bulk Actions:
Date Filing Language Size Actions
2024-12-15
English
4.2 MB
2024-10-30
German
1.8 MB
2024-08-14
French
0.5 MB
2024-05-22
English
2.1 MB
2024-03-10
English
3.5 MB
2024-01-15
German
1.2 MB
2023-11-20
English
5.1 MB

Full Filing History Restricted

Access to specific historical documents or filtered results is limited in the Web UI. Request access to the complete dataset.

Automate Your Workflow. Get a real-time feed of all NovaBay Pharmaceuticals, Inc. filings delivered via API.

Explore Data Feeds →

Market Data

Market Data Not Available

Financials & KPIs

No data available

Unlock Full Financials for NovaBay Pharmaceuticals, Inc.

This data is available as part of our premium data solutions. Contact our team for access.

Need More History? Access decades of standardized financials for NovaBay Pharmaceuticals, Inc. via our API.

Get Historical Data →

Insider Transactions

Date Insider Name Position Type Shares Value
No insider transactions recorded for this company.

Peer Companies

Clinical-stage biopharma developing therapies for neuropsychiatric diseases.
United States of America
LBRX
L&C BIO Co., Ltd Logo
Develops and manufactures human tissue-based medical devices for regenerative medicine.
South Korea
290650
LEAP THERAPEUTICS, INC. Logo
Clinical-stage biopharma developing targeted immuno-oncology therapies for cancer.
United States of America
LPTX
Legend Biotech Corp Logo
A biotech company that develops and commercializes novel cell therapies for diseases.
United States of America
LEGN
LENZ Therapeutics, Inc. Logo
A late-stage pharmaceutical company developing an eye drop to treat presbyopia.
United States of America
LENZ
Lexeo Therapeutics, Inc. Logo
A clinical-stage company developing AAV gene therapies for genetic diseases.
United States of America
LXEO
LEXICON PHARMACEUTICALS, INC. Logo
A biopharmaceutical company developing medicines using gene science and genetics.
United States of America
LXRX
Lidds AB Logo
Develops a drug delivery technology for local, controlled, and sustained release.
Sweden
LIDDS
LIFECORE BIOMEDICAL, INC. \DE\ Logo
A CDMO for sterile injectables and producer of non-animal-sourced hyaluronic acid.
United States of America
LFCR
Liminatus Pharma, Inc. Logo
A pre-clinical biopharma company developing immune-modulating cancer therapies.
United States of America
LIMN

Report Sent!

Thank you. We will check the data and update it shortly.

Talk to a Data Expert

Have a question? We'll get back to you promptly.